425.395.8685 contact@rjshara.biz
Indian health care startup PharmEasy to acquire majority stake in listed company Thyrocare for over $600 million

Indian health care startup PharmEasy to acquire majority stake in listed company Thyrocare for over $600 million

by | Jun 25, 2021 | Fundings and Exit

API Holdings, which operates the giant health care start-up PharmEasy, stated on Friday it has actually reached an arrangement to acquire a 66.1% stake in Thyrocare, which runs a diagnostic lab chain, for about $613 million in what is the very first acquisition of an openly listed company by an unicorn start-up worldwide’s 2nd most […] (PDF) to a local exchange, Thyrocare has actually divulged that API Holdings plans to raise another financing round, where it might offer about 4.9% stake to Dr. A. Veluman, a promoter of Thyrocare, for about $202 million. PharmEasy, the only healthcare unicorn startup in India, is the country’s largest online pharmacy and diagnostics brand name. Thyrocare is India’s largest diagnostics service provider by volume (it performs over 110 million tests in a year).”We are happy to be partnering Thyrocare….

Zeta in talks with SoftBank to raise at over $1 billion valuation

by | Apr 14, 2021 | Startups

Banking tech start-up Zeta is inching closer to the much sought-after unicorn status as it engages with financiers to finalize a brand-new round, 2 sources knowledgeable about the matter told TechCrunch. SoftBank Vision Fund 2 remains in sophisticated phases of speak with lead a ~ $250 million Series D round in the five-year-old start-up, the sources […]
SoftBank Vision Fund 2 is in advanced phases of talks to lead a ~$250 million Series D round in the five-year-old startup, the sources stated. Five-year-old Zeta helps banks launch contemporary retail and fintech items. The story was updated with extra details and to note that the round hasn’t closed. …